Page 6 - Kiran Mazumdar-shaw

Why CMD role separation remains a work in progress despite deadline nearing

Sebi, in its October 2017 report on corporate governance, said listed firms should have a different person heading the management and another in place as chairman of the board

When Rahul Bajaj, Kiran Mazumdar-Shaw broke deafening silence of India Inc

In visible signs of economic woes, the auto sector went through one of the longest sales slumps leading to nearly 3.5 lakh job losses.

Biocon elevates Chief Financial Officer Siddharth Mittal as Joint MD & CEO

Mittal takes over from Arun Chandavarkar, who retired on November 30 after 29 years at Biocon

Siddharth Mittal succeeds Arun Chandavarkar as CEO, Joint MD of Biocon

Bengaluru-headquartered biopharmaceuticals company Biocon Ltd on Tuesday said Siddharth Mittal has taken over as its chief executive officer and joint managing director. "Siddharth Mittal has taken over as Chief Executive Officer & Joint Managing Director of the company starting December 1, 2019," the company said in a BSE filing. Mittal has been serving as Chief Financial Officer (CFO) of Biocon since August 2014, the filing said. Mittal takes over from Arun Chandavarkar who retired as chief executive and joint MD of the company on November 30. "I am very pleased to welcome Siddharth as CEO & Joint MD of Biocon," Biocon CMD Kiran Mazumdar-Shaw said.

India Inc neither 'anti-national nor anti-government': Kiran Mazumdar Shaw

Supporting Bajaj, Shaw had earlier said, 'Hope the govt reaches out to India Inc for working out solutions to revive consumption n growth'

Always better to seek an answer than spreading one's own impression: FM

Kiran Mazumdar- Shaw says India Inc is treated as pariahs

India Inc is a pariah, feels govt dislikes criticism: Kiran Mazumdar Shaw

Shaw's remarks came a day after veteran industrialist Rahul Bajaj said the people were afraid to criticise the government.

GDP shocker: India Inc expects growth to rebound in Q3 on stimulus measures

Biocon CMD Kiran Mazumdar-Shaw opined that few pragmatic policies can help put India on the top again

USFDA approves production of Biocon biosimilar at new Bengaluru unit

The US Food and Drug Administration's (USFDA's) nod to Biocon's supplemental biologics licence application for the new unit will expand the company's capacity multifold, the company said

Kiran Mazumdar Shaw settles 'insider trading case' with Sebi in Infy matter

Accordingly, she filed a settlement application without admitting or denying the default and remitted Rs 3,01,758 in September 2019.

Insulin at Rs 7 will be a gamechanger for us: Biocon's Kiran Mazumdar-Shaw

'We are trying to develop a strategy where we could make people to stop using disposable plastic devices', said Shaw

Biocon posts profit before tax of Rs 354 cr for quarter ended September 30

Excluding the exceptional item, the PBT grew 9 per cent on year-on-year basis

FM versus Biocon chief on Twitter over e-cigarettes settles amicably

Shaw, head of Biocon, had earlier wondered why the finance minister, and not the health minister, addressed the press conference

CEOs bank on festive cheer; India Inc hopes for improvement in second half

Demand to pick up from festival season next month, say corporate leaders

Kiran Mazumdar-Shaw on curing cancer and the perils of a divisive society

Shaw says she tells her pharma colleagues that they are in a humanitarian business - like it or not, patients come first and if patients are the focus, profits would come naturally

Infosys says Kiran Mazumdar-Shaw sold 1,600 shares without pre-clearance

The Trade was carried out by the portfolio manager without the knowledge of Ms Mazumdar-Shaw

Biocon's US generic formulations grew seven-fold in Q3: Kiran Mazumdar-Shaw

Biocon's year-to-date earnings have more than doubled over last year, led by the biologics segment, says Shaw

Kiran Shaw, Kannada Development Authority spar over English medium classes

A war of words has erupted between Biocon chief Kiran Mazumdar Shaw and Kannada Development Authority after she called the KDA "an insignificant group of nay sayers" for opposing the state government's proposal to introduce English medium classes in 1,000 primary schools. "Media always portrays a small & insignificant group of nay sayers as 'activists' - these r usually attention seeking trouble makers who don't care about education nor employment (sic)," Shaw tweeted on July 7, referring to KDA's stand on the issue. That day the KDA chairman had led a delegation to Chief Minister H D Kumaraswamy, urging him to rollback the proposal to introduce English medium classes in the schools and instead encourage education in the mother tongue, Kannada. The delegation comprised freedom fighter H S Doreswamy and writers Chandrashekar Kambar, Chandrashekar Patil and M Chidanandamurthy. Responding to KDA's stand, Shaw said "political malcontents" are trying to play mischief with her tweets ...

Price controls will devalue healthcare system in India: Kiran Mazumdar-Shaw

Kiran Mazumdar Shaw, chairman and managing director of Biocon has called on the Centre to be careful in controlling prices of drugs and equipment saying that this could potentially impact the quality of healthcare in India. "I think there is an affordability price-point which people need to understand and that is the debate we are not having. Just by forcing pricing on hospital services and drugs, what is happening today? There is a drug shortage, poor quality drug being offered. If you want cheap (more price control) you will devalue the entire healthcare system in India. I think the cost of healthcare in India is the lowest in the world and let us not forget that. You are not going to have quality stents and implants to use in surgery, are not you doing a disservice to patients," said Shaw. She was talking to reporters here at an event to announce GE Healthcare's partnership with medtech startup UE LifeSciences. National Pharmaceuticals Pricing Authority (NPPA) has recently ...

Ban open burning of all wastes, says Biocon's Kiran Mazumdar-Shaw

Mazumdar-Shaw said air pollution is a serious hazard which has already taken its toll in Delhi